ArticleACS medicinal chemistry letters2026

Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

Kathrin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.